2nd Peptide-Based Therapeutics Summit

Date : 1st April 2025 to 3rd April 2025

Place : United States of America, Boston

Website :https://peptide-based-therapeutics-summit.com/

Contact Person:Kate Woodford

Description:

Identify, Synthesize and Design Optimized Peptide-Based Drugs. Time: 8:00 AM - 5:00 PM. Prices: USD 2599.00 - USD 5197.00. Speakers: Abbas Walji, Senior Director, Discovery Chemistry, Merck, and more

2nd Peptide-Based Therapeutics Summit will be held in Boston,United States of America on date 2025-04-03

---

Deadline for abstracts/proposals : 1st April 2025

Keynote Speakers :

Conference Highlights :Home - 2nd Peptide-Based Therapeutics Summit
Join us in April 2025 for the 2nd Peptide-Based Therapeutics Summit to identify, synthesize & design optimized peptide-based drugs.

Join Our Group!
WithMerck’soral PCSK9 inhibitor demonstrating strong phase 3 trial results,J&J’sIL23R antagonist peptide continuing its phase 3 journey, andChugaiadvancing peptides into the intracellular space, peptide therapeutics are firmly back on the map as the next modality disrupting drug discovery and development.
This includes exploringpeptide structure predictionusing AI/ML technologies, designingorally bioavailableandcell membrane-permeablepeptidesusing structure-based molecular design, harnessingmRNA displayandDNA-encoded librariesfor peptide discovery,optimizingpeptide synthesis, integratingformulationconsiderations at the discovery stage, and investigating peptides asdrug delivery vehicles.
The2nd Peptide-Based Therapeutics Summitreturns toBostonas your most comprehensive, industry-dedicated forum for overcoming the unique drug discovery challenges of peptide-based therapeutics and powering up your development pipelines to achieve 2025/26 milestones.
As this revitalized space reaches a critical tipping point, join the conversation on how advancements incomputational,medicinalchemistry, andformulation technologiesare driving peptide pipeline progression from hit to lead.

Check the event website for more details.